Your browser doesn't support javascript.
loading
Progression of hemolysis in a patient with hereditary spherocytosis after the second dose of COVID-19 mRNA vaccine.
Nomura, Jun; Seki, Masafumi; Abe, Syori; Kobayashi, Tadahiro; Okitsu, Yoko; Fukuhara, Noriko; Takahashi, Shinichiro; Harigae, Hideo; Kameoka, Junichi.
Afiliação
  • Nomura J; Department of Hematology and Rheumatology, Tohoku Medical and Pharmaceutical University, Sendai-shi, Japan.
  • Seki M; Department of Infectious Diseases and Infection Control, International Medical Center, Saitama Medical University School of Medicine, Saitama, Japan.
  • Abe S; Department of Hematology and Rheumatology, Tohoku Medical and Pharmaceutical University, Sendai-shi, Japan.
  • Kobayashi T; Department of Hematology and Rheumatology, Tohoku Medical and Pharmaceutical University, Sendai-shi, Japan.
  • Okitsu Y; Department of Hematology and Rheumatology, Tohoku Medical and Pharmaceutical University, Sendai-shi, Japan.
  • Fukuhara N; Department of Hematology, Tohoku University, Sendai-shi, Japan.
  • Takahashi S; Department of Hematology and Rheumatology, Tohoku Medical and Pharmaceutical University, Sendai-shi, Japan.
  • Harigae H; Department of Hematology, Tohoku University, Sendai-shi, Japan.
  • Kameoka J; Department of Hematology and Rheumatology, Tohoku Medical and Pharmaceutical University, Sendai-shi, Japan.
Hum Vaccin Immunother ; 19(1): 2165381, 2023 12 31.
Article em En | MEDLINE | ID: mdl-36625832

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 Limite: Adult / Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 Limite: Adult / Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article